Ortin Global Ltd Quarterly Results
Q1 FY12-13 Results Summary
Revenue
The revenue stands at ₹15.93 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.42 per cent from ₹19.77 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹2.08 crore, reflecting a quarter-on-quarter *(QoQ) increase of 308.00 per cent from ₹-1.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹0.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 155.31 per cent from ₹-1.79 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 130.28 per cent from ₹-2.18 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹0.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 122.92 per cent from ₹-1.92 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Ortin Global Ltd Earnings
- YOY
- QOQ
Ortin Global Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ortin Global Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Ortin Global Ltd Financial Reports
Ortin Global Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Norris Medicines | -3.39% | 0.07% | 3.64% | -3.46% | -9.00% | -20.39% |
| Beryl Drugs | 4.99% | -1.92% | 21.02% | 9.34% | 8.87% | 15.29% |
| Parmax Pharma | 0.00% | 0.71% | 16.88% | -19.20% | -8.36% | -27.86% |
| Hind.Bio Science | 4.79% | 8.32% | 28.40% | 54.82% | 18.01% | 9.43% |
| Unjha Formul. | -4.78% | -7.23% | -6.20% | -12.98% | -18.78% | -15.06% |
| Decipher Labs | 8.59% | 5.34% | 32.62% | -0.49% | -15.11% | -28.41% |
| Vivanza Biosci. | -1.96% | 0.50% | 5.26% | -6.98% | 1.01% | -14.16% |
Company Info
Company Information
Managing Director : S Murali Krishna Murthy
Non Executive Director : Pramod Dnyandeo Wag He
Independent Director : Mounika Pammi
Whole-time Director : Prashant Prakash Sawant
Whole-time Director : Prakruti Prakash Sawant
Chairman & Independent Directo : Sarang Balbhimrao Patodekar
Independent Director : Ajay Vishwakarma
Company Sec. & Compli. Officer : Madhu Solanki